Amgen issues bullish forecast for 'dmab' franchise
April 21 2011
At the biotech's business update meeting today, Amgen president and COO, Robert Bradway, said he hopes to build the denosumab ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.